Total Funding
85
66
Total FundingSeries C raised
Growth Score
-8 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
31500
IMBiologics is a biotechnology company that develops immunomodulatory antibody drugs for physiological balance.
- Kim Wan-jun: CFO
Jeong In-su: Chief Operating Officer
About the Company
IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules.
